Atlas Trials

Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19

Clinical trial NCT04542980 · COMPLETED

Trial details

NCT number
NCT04542980
Sponsor
Namida Lab
Status
COMPLETED
Study type
OBSERVATIONAL
SARS-CoV 2 InfectionCovid19
Start date
2020-09-15
Primary completion
2020-12-31
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.